Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S, Pedersini R, Birtolo MF, Baruch NL, Carrone F, Jaafar S, Ciafardini A, Cosentini D, Laganà M, Torrisi R, Farina D, Leonardi L, Balzarini L, Vena W, Bossi AC, Zambelli A, Lania AG, Berruti A, Mazziotti G.
Antonini S, et al. Among authors: leonardi l.
J Endocrinol Invest. 2024 Feb;47(2):433-442. doi: 10.1007/s40618-023-02174-5. Epub 2023 Aug 17.
J Endocrinol Invest. 2024.
PMID: 37592052